Reata Pharmaceuticals Inc. shares were recently down 30% to $38 after hours after the company received a negative opinion from a Food and Drug Administration advisory committee for its new drug ...
网页链接Reata Pharmaceuticals Inc. shares were recently down 30% to $38 after hours after the company received a negative opinion from a Food and Drug Administration advisory committee for its new drug ...
网页链接
精彩评论